Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Vaccine
|
December 20, 2008
Microbiology of otitis media: a moving target
Anne Vergison
Expert Opinion on Biological Therapy
|
November 24, 2007
Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines
Philippe Lepage, Anne Vergison
The Pediatric Infectious Disease Journal
|
March 16, 2012
Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance
Anne Vergison, Germaine Hanquet
Expert Review of Anti-Infective Therapy
|
June 19, 2012
Impact of rotavirus vaccines on rotavirus disease
Philippe Lepage, Anne Vergison
The Lancet. Infectious Diseases
|
March 23, 2007
Streptococcus pneumoniae incidence in western Europe
Anne Vergison, Ralf R Reinert
Pediatrics
|
August 9, 2006
Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough
Anne Vergison, David Tuerlinckx, Jan Verhaegen, et al.
International Journal of Pediatric Otorhinolaryngology
|
December 31, 2013
Acute otitis media in young children - what do parents say?
Colin Barber, Susanne Ille, Anne Vergison, et al.
Epidemiology and Infection
|
December 25, 2025
Protection from second booster vaccines and natural immunity against SARS-CoV-2 infections, 2022-2023
Dritan Bejko, Anne Vergison, Saverio Stranges, et al.
The Pediatric Infectious Disease Journal
|
March 26, 2011
Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium
Marc Raes, Danielle Strens, Anne Vergison, et al.
International Journal of Antimicrobial Agents
|
March 10, 2009
Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations
Pierre Robert Smeesters, Anne Vergison, Dioclécio Campos Junior, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Vaccine
|
December 20, 2008
Microbiology of otitis media: a moving target
Anne Vergison
Expert Opinion on Biological Therapy
|
November 24, 2007
Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines
Philippe Lepage, Anne Vergison
The Pediatric Infectious Disease Journal
|
March 16, 2012
Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance
Anne Vergison, Germaine Hanquet
Expert Review of Anti-Infective Therapy
|
June 19, 2012
Impact of rotavirus vaccines on rotavirus disease
Philippe Lepage, Anne Vergison
The Lancet. Infectious Diseases
|
March 23, 2007
Streptococcus pneumoniae incidence in western Europe
Anne Vergison, Ralf R Reinert
Pediatrics
|
August 9, 2006
Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough
Anne Vergison, David Tuerlinckx, Jan Verhaegen, et al.
International Journal of Pediatric Otorhinolaryngology
|
December 31, 2013
Acute otitis media in young children - what do parents say?
Colin Barber, Susanne Ille, Anne Vergison, et al.
Epidemiology and Infection
|
December 25, 2025
Protection from second booster vaccines and natural immunity against SARS-CoV-2 infections, 2022-2023
Dritan Bejko, Anne Vergison, Saverio Stranges, et al.
The Pediatric Infectious Disease Journal
|
March 26, 2011
Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium
Marc Raes, Danielle Strens, Anne Vergison, et al.
International Journal of Antimicrobial Agents
|
March 10, 2009
Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations
Pierre Robert Smeesters, Anne Vergison, Dioclécio Campos Junior, et al.
Page
of 5